{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:22:16Z","timestamp":1790266936860,"version":"4.1.0"},"reference-count":176,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"FP7 Marie Curie CIG","award":["304221"],"award-info":[{"award-number":["304221"]}]},{"name":"Netherlands Lung Foundations","award":["9.2.15.066FE"],"award-info":[{"award-number":["9.2.15.066FE"]}]},{"DOI":"10.13039\/501100003793","name":"Swedish Heart Lung Foundation","doi-asserted-by":"publisher","award":["20130321"],"award-info":[{"award-number":["20130321"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001862","name":"The Swedish Research Council","doi-asserted-by":"crossref","award":["K2013-57X-14182-12-3"],"award-info":[{"award-number":["K2013-57X-14182-12-3"]}],"id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"crossref"}]},{"name":"King Oscar II Jubilee Foundation"},{"name":"King Gustaf V's and Queen Victoria's Freemasons' Foundation"},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["3-1818\/2013"],"award-info":[{"award-number":["3-1818\/2013"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jaut.2017.12.012","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T16:31:28Z","timestamp":1515169888000},"page":"82-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Th17-lineage cells in pulmonary sarcoidosis and L\u00f6fgren's syndrome: Friend or foe?"],"prefix":"10.1016","volume":"87","author":[{"given":"Jelle R.","family":"Miedema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2946-8718","authenticated-orcid":false,"given":"Ylva","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline E.","family":"Broos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies S.","family":"Wijsenbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Grunewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Kool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2017.12.012_bib1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0923-1811(02)00148-2","article-title":"Monocyte-derived multinucleated giant cells and sarcoidosis","volume":"31","author":"Okamoto","year":"2003","journal-title":"J.\u00a0Dermatol. Sci."},{"key":"10.1016\/j.jaut.2017.12.012_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1749-6632.1976.tb47010.x","article-title":"Immunologic components of granuloma formation. Epithelioid cells, giant cells, and sarcoidosis","volume":"278","author":"Spector","year":"1976","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jaut.2017.12.012_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/MOH.0000000000000301","article-title":"Mechanism of granuloma formation in sarcoidosis","volume":"24","author":"Sakthivel","year":"2017","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.jaut.2017.12.012_bib4","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.4049\/jimmunol.156.12.4952","article-title":"Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis","volume":"156","author":"Moller","year":"1996","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib5","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/MCP.0000000000000303","article-title":"T-cell immunology in sarcoidosis: disruption of a delicate balance between helper and regulatory T-cells","volume":"22","author":"Broos","year":"2016","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib6","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1172\/JCI111852","article-title":"Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis","volume":"75","author":"Robinson","year":"1985","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.jaut.2017.12.012_bib7","doi-asserted-by":"crossref","first-page":"642","DOI":"10.4049\/jimmunol.166.1.642","article-title":"IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs","volume":"166","author":"Shigehara","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib8","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1089\/jir.2006.26.400","article-title":"Upregulation of Th1 cytokine profile (IL-12, IL-18) in bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis","volume":"26","author":"Antoniou","year":"2006","journal-title":"J.\u00a0Interferon Cytokine Res."},{"key":"10.1016\/j.jaut.2017.12.012_bib9","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","article-title":"Sarcoidosis","volume":"383","author":"Valeyre","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2017.12.012_bib10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/17476348.2017.1281745","article-title":"Strategies for identifying pulmonary sarcoidosis patients at risk for severe or chronic disease","volume":"11","author":"Judson","year":"2017","journal-title":"Expet Rev. Respir. Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib11","first-page":"119","article-title":"The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States","volume":"29","author":"Judson","year":"2012","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.jaut.2017.12.012_bib12","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ccm.2004.04.006","article-title":"Pulmonary sarcoidosis","volume":"25","author":"Baughman","year":"2004","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib13","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib14","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1034\/j.1399-3003.1999.14d02.x","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. Sarcoidosis statement committee. American thoracic society. European respiratory society. World association for sarcoidosis and other granulomatous disorders","volume":"14","author":"Costabel","year":"1999","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2017.12.012_bib15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1164\/rccm.200807-1082OC","article-title":"Lofgren's syndrome: human leukocyte antigen strongly influences the disease course","volume":"179","author":"Grunewald","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib16","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1164\/rccm.201507-1372OC","article-title":"High-density genetic mapping identifies new susceptibility variants in sarcoidosis phenotypes and shows genomic-driven phenotypic differences","volume":"193","author":"Rivera","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib17","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.0954-6820.1953.tb07044.x","article-title":"Primary pulmonary sarcoidosis. II. Clinical course and prognosis","volume":"145","author":"Lofgren","year":"1953","journal-title":"Acta Med. Scand."},{"key":"10.1016\/j.jaut.2017.12.012_bib18","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.0954-6820.1953.tb07039.x","article-title":"Primary pulmonary sarcoidosis. I. Early signs and symptoms","volume":"145","author":"Lofgren","year":"1953","journal-title":"Acta Med. Scand."},{"key":"10.1016\/j.jaut.2017.12.012_bib19","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0002-9343(99)00223-5","article-title":"Lofgren's syndrome revisited: a study of 186 patients","volume":"107","author":"Mana","year":"1999","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1164\/rccm.200608-1197OC","article-title":"Sex-specific manifestations of Lofgren's syndrome","volume":"175","author":"Grunewald","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.0954-6820.1952.tb13864.x","article-title":"The bilateral hilar lymphoma syndrome; a study of the relation to age and sex in 212 cases","volume":"142","author":"Lofgren","year":"1952","journal-title":"Acta Med. Scand."},{"key":"10.1016\/j.jaut.2017.12.012_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1465-9921-11-25","article-title":"Different HLA-DRB1 allele distributions in distinct clinical subgroups of sarcoidosis patients","volume":"11","author":"Grunewald","year":"2010","journal-title":"Respir. Res."},{"key":"10.1016\/j.jaut.2017.12.012_bib23","first-page":"118","article-title":"Sarcoidosis in Spain","volume":"9","author":"Mana","year":"1992","journal-title":"Sarcoidosis"},{"key":"10.1016\/j.jaut.2017.12.012_bib24","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1093\/hmg\/ddq325","article-title":"Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups","volume":"19","author":"Sato","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jaut.2017.12.012_bib25","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1620\/tjem.234.137","article-title":"A\u00a0Japanese patient with Lofgren's syndrome with an HLA-DR12 allele and review of literature on Japanese patients","volume":"234","author":"Ishimatsu","year":"2014","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib27","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.humimm.2011.03.020","article-title":"Human leukocyte antigen-A, -B, and -DRB1 alleles and sarcoidosis in Chinese Han subjects","volume":"72","author":"Zhou","year":"2011","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib28","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1183\/13993003.00092-2016","article-title":"Expanded lung T-bet+RORgammaT+ CD4+ T-cells in sarcoidosis patients with a favourable disease phenotype","volume":"48","author":"Kaiser","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2017.12.012_bib29","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.coi.2015.03.007","article-title":"Regulation of human helper T cell subset differentiation by cytokines","volume":"34","author":"Schmitt","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib31","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1074\/jbc.M207577200","article-title":"Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17","volume":"278","author":"Aggarwal","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jaut.2017.12.012_bib32","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/ni.1613","article-title":"A\u00a0critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses","volume":"9","author":"Volpe","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib33","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/0091-6749(93)90352-G","article-title":"Increased secretion of tumor necrosis factor-alpha, interleukin-1-beta, and interleukin-6 by alveolar macrophages from patients with sarcoidosis","volume":"91","author":"Steffen","year":"1993","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib34","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1365-2249.2003.02105.x","article-title":"Increased circulating interleukin-12 (IL-12) p40 in pulmonary sarcoidosis","volume":"132","author":"Shigehara","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib35","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1183\/09031936.98.12040913","article-title":"Transforming growth factor-beta1 in sarcoidosis","volume":"12","author":"Salez","year":"1998","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2017.12.012_bib36","doi-asserted-by":"crossref","first-page":"6915","DOI":"10.4049\/jimmunol.0900074","article-title":"In situ IL-12\/23p40 production during mycobacterial infection is sustained by CD11bhigh dendritic cells localized in tissue sites distinct from those harboring bacilli","volume":"182","author":"Rothfuchs","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib37","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jaad.2011.06.017","article-title":"Molecular profiling and gene expression analysis in cutaneous sarcoidosis: the role of interleukin-12, interleukin-23, and the T-helper 17 pathway","volume":"66","author":"Judson","year":"2012","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"key":"10.1016\/j.jaut.2017.12.012_bib38","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1365-2249.2000.01365.x","article-title":"Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells","volume":"122","author":"Prasse","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib39","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1128\/IAI.69.4.2596-2603.2001","article-title":"Mycobacterium bovis BCG-induced granuloma formation depends on gamma interferon and CD40 ligand but does not require CD28","volume":"69","author":"Hogan","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jaut.2017.12.012_bib40","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0092-8674(89)90676-4","article-title":"The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection","volume":"56","author":"Kindler","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2017.12.012_bib41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4049\/jimmunol.0903856","article-title":"Understanding latent tuberculosis: a moving target","volume":"185","author":"Lin","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib42","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1084\/jem.178.6.2243","article-title":"Disseminated tuberculosis in interferon gamma gene-disrupted mice","volume":"178","author":"Cooper","year":"1993","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib43","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection","volume":"178","author":"Flynn","year":"1993","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib44","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1128\/IAI.69.3.1847-1855.2001","article-title":"Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology","volume":"69","author":"Mohan","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jaut.2017.12.012_bib45","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/thx.2010.140319","article-title":"Sarcoidosis is a Th1\/Th17 multisystem disorder","volume":"66","author":"Facco","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.jaut.2017.12.012_bib46","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/rheumatology\/ker316","article-title":"Increased IL-17A expression in granulomas and in circulating memory T cells in sarcoidosis","volume":"51","author":"Ten Berge","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2017.12.012_bib47","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s10875-012-9817-6","article-title":"Sarcoidosis Th17 cells are ESAT-6 antigen specific but demonstrate reduced IFN-gamma expression","volume":"33","author":"Richmond","year":"2013","journal-title":"J.\u00a0Clin. Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib48","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/438070","article-title":"Bronchoalveolar lavage fluid IFN-gamma+ Th17 cells and regulatory T cells in pulmonary sarcoidosis","volume":"2014","author":"Tondell","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jaut.2017.12.012_bib49","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/cei.12403","article-title":"Higher levels of interleukin IL-17 and antigen-specific IL-17 responses in pulmonary sarcoidosis patients with Lofgren's syndrome","volume":"178","author":"Ostadkarampour","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib50","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.4049\/jimmunol.0903332","article-title":"Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung","volume":"184","author":"Okamoto Yoshida","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib51","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nm1694","article-title":"Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion","volume":"14","author":"Coury","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib52","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nature06471","article-title":"Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease","volume":"451","author":"Romani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2017.12.012_bib53","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.4049\/jimmunol.160.7.3513","article-title":"IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages","volume":"160","author":"Jovanovic","year":"1998","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib54","unstructured":"Kveim., 1941;9:169."},{"key":"10.1016\/j.jaut.2017.12.012_bib55","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/jama.1961.03040440028006","article-title":"The Kveim test in sarcoidosis. A study of 750 patients","volume":"178","author":"Siltzbach","year":"1961","journal-title":"JAMA"},{"key":"10.1016\/j.jaut.2017.12.012_bib56","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0140-6736(98)12310-3","article-title":"Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis","volume":"354","author":"Ishige","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2017.12.012_bib57","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1128\/JCM.40.1.198-204.2002","article-title":"Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis","volume":"40","author":"Eishi","year":"2002","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.jaut.2017.12.012_bib58","first-page":"251","article-title":"Bacteriological investigation on biopsy specimens from patients with sarcoidosis","volume":"48","author":"Homma","year":"1978","journal-title":"Jpn. J. Exp. Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib59","first-page":"541","article-title":"Frequent isolation of Propionibacterium acnes from sarcoidosis lymph nodes","volume":"256","author":"Abe","year":"1984","journal-title":"Zentralbl. Bakteriol. Mikrobiol. Hyg. A"},{"key":"10.1016\/j.jaut.2017.12.012_bib60","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/935289","article-title":"Etiologic aspect of sarcoidosis as an allergic endogenous infection caused by Propionibacterium acnes","volume":"2013","author":"Eishi","year":"2013","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.jaut.2017.12.012_bib61","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1183\/13993003.01209-2015","article-title":"T-cell receptor-HLA-DRB1 associations suggest specific antigens in pulmonary sarcoidosis","volume":"47","author":"Grunewald","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2017.12.012_bib62","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1074\/mcp.M116.060764","article-title":"Approach for identifying human leukocyte antigen (HLA)-DR bound peptides from scarce clinical samples","volume":"15","author":"Heyder","year":"2016","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.jaut.2017.12.012_bib63","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1172\/JCI32401","article-title":"Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis","volume":"117","author":"Wahlstrom","year":"2007","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.jaut.2017.12.012_bib64","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.clim.2009.08.008","article-title":"Autoimmune T cell responses to antigenic peptides presented by bronchoalveolar lavage cell HLA-DR molecules in sarcoidosis","volume":"133","author":"Wahlstrom","year":"2009","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170285","article-title":"Proteomic analysis of Kveim reagent identifies targets of cellular immunity in sarcoidosis","volume":"12","author":"Eberhardt","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2017.12.012_bib66","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1164\/rccm.201407-1341OC","article-title":"Proteomic profiling reveals autoimmune targets in sarcoidosis","volume":"191","author":"Haggmark","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib67","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12016-015-8481-z","article-title":"Etiologies of sarcoidosis","volume":"49","author":"Chen","year":"2015","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib68","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1378\/chest.06-2114","article-title":"World Trade Center \u201csarcoid-like\u201d granulomatous pulmonary disease in New York City Fire Department rescue workers","volume":"131","author":"Izbicki","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.jaut.2017.12.012_bib69","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.rmed.2017.06.004","article-title":"Post-9\/11 sarcoidosis in WTC-exposed firefighters and emergency medical service workers","volume":"132","author":"Webber","year":"2017","journal-title":"Respir. Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib70","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/tan.12326","article-title":"HLA-alleles associated with increased risk for extra-pulmonary involvement in sarcoidosis","volume":"83","author":"Darlington","year":"2014","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jaut.2017.12.012_bib71","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1183\/09031936.00025011","article-title":"HLA-DRB1* alleles and symptoms associated with Heerfordt's syndrome in sarcoidosis","volume":"38","author":"Darlington","year":"2011","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2017.12.012_bib72","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3389\/fimmu.2017.00422","article-title":"SNP variants in major histocompatibility complex are associated with sarcoidosis susceptibility-a joint analysis in four European populations","volume":"8","author":"Wolin","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib73","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.4049\/jimmunol.1201760","article-title":"Butyrophilin-like 2 modulates B7 costimulation to induce Foxp3 expression and regulatory T cell development in mature T cells","volume":"190","author":"Swanson","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib74","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2796.2008.01984.x","article-title":"A\u00a0common haplotype of the C-C chemokine receptor 2 gene and HLA-DRB1*0301 are independent genetic risk factors for Lofgren's syndrome","volume":"264","author":"Spagnolo","year":"2008","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib75","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1164\/rccm.200412-1707OC","article-title":"C-C chemokine receptor 5 gene variants in relation to lung disease in sarcoidosis","volume":"172","author":"Spagnolo","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib76","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/jhg.2013.2","article-title":"Exome sequencing identifies novel rheumatoid arthritis-susceptible variants in the BTNL2","volume":"58","author":"Mitsunaga","year":"2013","journal-title":"J.\u00a0Hum. Genet."},{"key":"10.1016\/j.jaut.2017.12.012_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004955","article-title":"Pooled sequencing of 531 genes in inflammatory bowel disease identifies an associated rare variant in BTNL2 and implicates other immune related genes","volume":"11","author":"Prescott","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jaut.2017.12.012_bib78","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12931-015-0265-8","article-title":"Impaired survival of regulatory T cells in pulmonary sarcoidosis","volume":"16","author":"Broos","year":"2015","journal-title":"Respir. Res."},{"key":"10.1016\/j.jaut.2017.12.012_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043907","article-title":"Genome-wide association study of African and European Americans implicates multiple shared and ethnic specific loci in sarcoidosis susceptibility","volume":"7","author":"Adrianto","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2017.12.012_bib80","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/ng.198","article-title":"Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis","volume":"40","author":"Hofmann","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jaut.2017.12.012_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092646","article-title":"Admixture fine-mapping in African Americans implicates XAF1 as a possible sarcoidosis risk gene","volume":"9","author":"Levin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2017.12.012_bib82","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004466","article-title":"Annexin A11 (ANXA11) gene polymorphisms are associated with sarcoidosis in a Han Chinese population: a case-control study","volume":"4","author":"Feng","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaut.2017.12.012_bib83","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/gene.2012.48","article-title":"Association of ANXA11 genetic variation with sarcoidosis in African Americans and European Americans","volume":"14","author":"Levin","year":"2013","journal-title":"Gene Immun."},{"key":"10.1016\/j.jaut.2017.12.012_bib84","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1164\/rccm.201503-0418OC","article-title":"Identification of immune-relevant factors conferring sarcoidosis genetic risk","volume":"192","author":"Fischer","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib85","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1183\/09031936.00049410","article-title":"Association of inflammatory bowel disease risk loci with sarcoidosis, and its acute and chronic subphenotypes","volume":"37","author":"Fischer","year":"2011","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2017.12.012_bib86","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1084\/jem.20070663","article-title":"Phenotypic and functional features of human Th17 cells","volume":"204","author":"Annunziato","year":"2007","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib87","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.4049\/jimmunol.1203172","article-title":"Cutting edge: the pathogenicity of IFN-gamma-producing Th17 cells is independent of T-bet","volume":"190","author":"Duhen","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib88","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.4049\/jimmunol.0900732","article-title":"Cutting edge: IL-23 receptor gfp reporter mice reveal distinct populations of IL-17-producing cells","volume":"182","author":"Awasthi","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib89","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1164\/rccm.201507-1499OC","article-title":"IFN-gamma-producing T-helper 17.1 cells are increased in sarcoidosis and are more prevalent than T-helper type 1 cells","volume":"193","author":"Ramstein","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib90","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1084\/jem.20130301","article-title":"Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids","volume":"211","author":"Ramesh","year":"2014","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib91","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","article-title":"Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial","volume":"61","author":"Hueber","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2017.12.012_bib92","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1002\/eji.201040539","article-title":"IFN-gamma and IL-12 synergize to convert in\u00a0vivo generated Th17 into Th1\/Th17 cells","volume":"40","author":"Lexberg","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib93","unstructured":"C.E. Broos, L.L. Koth, M. van Nimwegen, J.C.C.M. in \u2019t Veen, S.M.J. Paulissen, J.P. van Hamburg, J.T. Annema, R. Heller-Baan, A. Kleinjan, H.C. Hoogsteden, M.S. Wijsenbeek, R.W. Hendriks, B. van den Blink, M. Kool, Increased T helper 17.1 cells in sarcoidosis mediastinal lymph nodes, Eur. Resp. J. (accepted)."},{"key":"10.1016\/j.jaut.2017.12.012_bib94","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cyto.2015.02.002","article-title":"The role and modulation of CCR6+ Th17 cell populations in rheumatoid arthritis","volume":"74","author":"Paulissen","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.jaut.2017.12.012_bib95","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nrrheum.2015.128","article-title":"The IL-23-IL-17 axis in inflammatory arthritis","volume":"11","author":"Lubberts","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2017.12.012_bib96","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1183\/09031936.06.00067105","article-title":"Reduced Th1 response in the lungs of HLA-DRB1*0301 patients with pulmonary sarcoidosis","volume":"27","author":"Idali","year":"2006","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2017.12.012_bib97","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/ni.1882","article-title":"The dual nature of T(H)17 cells: shifting the focus to function","volume":"11","author":"O'Connor","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib98","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/eji.201444726","article-title":"TGF-beta converts Th1 cells into Th17 cells through stimulation of Runx1 expression","volume":"45","author":"Liu","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib99","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/ni.3099","article-title":"IL-1 signaling modulates activation of STAT transcription factors to antagonize retinoic acid signaling and control the TH17 cell-iTreg cell balance","volume":"16","author":"Basu","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib100","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2008-01-133967","article-title":"Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells","volume":"112","author":"Koenen","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2017.12.012_bib101","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1002\/eji.201243296","article-title":"CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner","volume":"43","author":"Afzali","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib102","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1182\/blood-2008-10-183251","article-title":"IL-17-producing human peripheral regulatory T cells retain suppressive function","volume":"113","author":"Beriou","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2017.12.012_bib103","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature14452","article-title":"Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation","volume":"523","author":"Gagliani","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2017.12.012_bib104","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.autrev.2011.05.004","article-title":"Human FoxP3+ regulatory T cells in systemic autoimmune diseases","volume":"10","author":"Miyara","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2017.12.012_bib105","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1164\/rccm.201503-0635LE","article-title":"Decreased cytotoxic T-lymphocyte antigen 4 expression on regulatory T cells and Th17 cells in sarcoidosis: double trouble?","volume":"192","author":"Broos","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib106","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000161122","article-title":"Anti-CTLA4 monoclonal antibody induced sarcoidosis in a metastatic melanoma patient","volume":"218","author":"Eckert","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.jaut.2017.12.012_bib107","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1200\/JCO.2011.37.9693","article-title":"Ipilimumab-induced sarcoidosis in a patient with metastatic melanoma undergoing complete remission","volume":"30","author":"Vogel","year":"2012","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.jaut.2017.12.012_bib108","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jdcr.2016.05.002","article-title":"Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy","volume":"2","author":"Suozzi","year":"2016","journal-title":"JAAD Case Rep."},{"key":"10.1016\/j.jaut.2017.12.012_bib109","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/bjd.14808","article-title":"Pulmonary sarcoid-like granulomatosis induced by nivolumab","volume":"176","author":"Montaudie","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2017.12.012_bib110","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1164\/rccm.201401-0188OC","article-title":"Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity","volume":"190","author":"Braun","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib111","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/j.chest.2015.10.082","article-title":"Nivolumab-induced sarcoid-like granulomatous reaction in a patient with advanced melanoma","volume":"149","author":"Danlos","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.jaut.2017.12.012_bib112","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jdcr.2017.02.015","article-title":"Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma","volume":"3","author":"Birnbaum","year":"2017","journal-title":"JAAD Case Rep."},{"key":"10.1016\/j.jaut.2017.12.012_bib113","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/1756-185X.13076","article-title":"Immunotherapy-induced sarcoidosis in patients with melanoma treated with PD-1 checkpoint inhibitors: case series and immunophenotypic analysis","volume":"20","author":"Lomax","year":"2017","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.12.012_bib114","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nri3108","article-title":"The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses","volume":"11","author":"Walker","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib115","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/cei.12942","article-title":"Sarcoidosis extent relates to molecular variability","volume":"188","author":"Monast","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib116","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.3746","article-title":"Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations","volume":"20","author":"Schubert","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib117","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.4049\/jimmunol.0903369","article-title":"Cutting edge: CTLA-4\u2013B7 interaction suppresses Th17 cell differentiation","volume":"185","author":"Ying","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib118","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.3389\/fimmu.2017.01130","article-title":"Mass cytometry identifies distinct lung CD4+ T cell patterns in Lofgren's syndrome and non-Lofgren's syndrome sarcoidosis","volume":"8","author":"Kaiser","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib119","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/1097-0142(19870301)59:5<896::AID-CNCR2820590507>3.0.CO;2-4","article-title":"Pulmonary sarcoidosis following interferon therapy for advanced renal cell carcinoma","volume":"59","author":"Abdi","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.jaut.2017.12.012_bib120","first-page":"140","article-title":"Sarcoidosis following beta-interferon therapy for multiple myeloma","volume":"12","author":"Bobbio-Pallavicini","year":"1995","journal-title":"Sarcoidosis"},{"key":"10.1016\/j.jaut.2017.12.012_bib121","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0168-8278(98)80357-7","article-title":"Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C","volume":"28","author":"Hoffmann","year":"1998","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jaut.2017.12.012_bib122","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2169\/internalmedicine.35.376","article-title":"Recurrence of sarcoidosis following interferon alpha therapy for chronic hepatitis C","volume":"35","author":"Nakajima","year":"1996","journal-title":"Intern. Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib123","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2169\/internalmedicine.35.19","article-title":"Sarcoidosis after interferon therapy for chronic active hepatitis C","volume":"35","author":"Teragawa","year":"1996","journal-title":"Intern. Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib124","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1086\/381094","article-title":"Sarcoidosis in HIV-infected patients in the era of highly active antiretroviral therapy","volume":"38","author":"Foulon","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jaut.2017.12.012_bib125","first-page":"125","article-title":"Recurrent Lofgren's syndrome in three patients with sarcoidosis","volume":"10","author":"Johard","year":"1993","journal-title":"Sarcoidosis"},{"key":"10.1016\/j.jaut.2017.12.012_bib126","article-title":"The plasticity of Th17 cells in the pathogenesis of rheumatoid arthritis","volume":"6","author":"Kotake","year":"2017","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib127","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1183\/09031936.00152607","article-title":"Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement","volume":"33","author":"Antoniou","year":"2009","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2017.12.012_bib128","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1164\/ajrccm.164.7.2103110","article-title":"Polymyositis-dermatomyositis-associated interstitial lung disease","volume":"164","author":"Douglas","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib129","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1164\/rccm.2106012","article-title":"Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome","volume":"165","author":"Bouros","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib130","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1164\/rccm.200403-417OC","article-title":"Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study","volume":"171","author":"Ito","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib131","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1465-9921-6-137","article-title":"Characterization of lymphocyte populations in nonspecific interstitial pneumonia","volume":"6","author":"Keogh","year":"2005","journal-title":"Respir. Res."},{"key":"10.1016\/j.jaut.2017.12.012_bib132","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/PAS.0b013e3182785a2d","article-title":"End-stage sarcoid lung disease is distinct from usual interstitial pneumonia","volume":"37","author":"Xu","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.jaut.2017.12.012_bib133","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/art.39971","article-title":"Progressive decline of lung function in rheumatoid arthritis-associated interstitial lung disease","volume":"69","author":"Zamora-Legoff","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2017.12.012_bib134","article-title":"Is there a role for IL-17 in the pathogenesis of systemic sclerosis?","author":"Chizzolini","year":"2017","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jaut.2017.12.012_bib135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005903","article-title":"The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes","volume":"4","author":"Radstake","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2017.12.012_bib136","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jdermsci.2008.01.001","article-title":"Clinical association of serum interleukin-17 levels in systemic sclerosis: is systemic sclerosis a Th17 disease?","volume":"50","author":"Murata","year":"2008","journal-title":"J.\u00a0Dermatol. Sci."},{"key":"10.1016\/j.jaut.2017.12.012_bib137","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K","article-title":"Increased interleukin-17 production in patients with systemic sclerosis","volume":"43","author":"Kurasawa","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.12.012_bib138","first-page":"765","article-title":"Frequency of Th1, Th2 and Th17 producing T lymphocytes in bronchoalveolar lavage of patients with systemic sclerosis","volume":"27","author":"Meloni","year":"2009","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2017.12.012_bib139","doi-asserted-by":"crossref","DOI":"10.1186\/ar3486","article-title":"Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease","volume":"13","author":"Truchetet","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2017.12.012_bib140","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/1756-185X.12290","article-title":"Interleukin-17 and interleukin-23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis","volume":"17","author":"Olewicz-Gawlik","year":"2014","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.12.012_bib141","article-title":"Th-17 cytokines and interstitial lung involvement in systemic sclerosis","volume":"10","author":"Rolla","year":"2016","journal-title":"J.\u00a0Breath Res."},{"key":"10.1016\/j.jaut.2017.12.012_bib142","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","volume":"160","author":"Statement on sarcoidosis","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"Suppl 5","key":"10.1016\/j.jaut.2017.12.012_bib143","article-title":"Interstitial lung disease guideline: the British thoracic society in collaboration with the thoracic society of Australia and New Zealand and the Irish thoracic society","volume":"63","author":"Bradley","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.jaut.2017.12.012_bib144","article-title":"Corticosteroids for pulmonary sarcoidosis","volume":"2","author":"Paramothayan","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jaut.2017.12.012_bib145","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1055\/s-0034-1376401","article-title":"Medical therapy of sarcoidosis","volume":"35","author":"Baughman","year":"2014","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib146","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.semarthrit.2017.03.005","article-title":"Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: a multicenter study of 132 patients","volume":"47","author":"Jamilloux","year":"2017","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.12.012_bib147","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1183\/09031936.00000914","article-title":"Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis","volume":"44","author":"Judson","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2017.12.012_bib148","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa1501646","article-title":"A\u00a0phase 2 trial of guselkumab versus adalimumab for plaque psoriasis","volume":"373","author":"Gordon","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib149","unstructured":"NCT02888080."},{"key":"10.1016\/j.jaut.2017.12.012_bib150","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/cei.12966","article-title":"The role of interleukin-6 signalling and its therapeutic blockage in skewing the T cell balance in rheumatoid arthritis","volume":"189","author":"Schinnerling","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib151","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.3899\/jrheum.130278","article-title":"Sarcoidosis induced by tocilizumab: a paradoxical event?","volume":"40","author":"Nutz","year":"2013","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2017.12.012_bib152","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1007\/s00296-010-1525-z","article-title":"A\u00a0fatal case of acute exacerbation of interstitial lung disease in a patient with rheumatoid arthritis during treatment with tocilizumab","volume":"32","author":"Kawashiri","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2017.12.012_bib153","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1183\/09059180.00001111","article-title":"Antifibrotic activities of pirfenidone in animal models","volume":"20","author":"Schaefer","year":"2011","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.jaut.2017.12.012_bib154","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1164\/rccm.201702-0351UP","article-title":"Update in interstitial lung disease 2016","volume":"196","author":"Wells","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib155","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.clim.2009.04.010","article-title":"Hypothesis: sarcoidosis is a STAT1-mediated disease","volume":"132","author":"Rosenbaum","year":"2009","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib156","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.gene.2016.09.037","article-title":"Bioinformatics analysis of gene expression profile data to screen key genes involved in pulmonary sarcoidosis","volume":"596","author":"Li","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.jaut.2017.12.012_bib157","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1038\/s41598-017-04109-6","article-title":"Identification of Jak-STAT signaling involvement in sarcoidosis severity via a novel microRNA-regulated peripheral blood mononuclear cell gene signature","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2017.12.012_bib158","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.4049\/jimmunol.1003668","article-title":"Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550)","volume":"186","author":"Ghoreschi","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib159","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s40265-017-0775-4","article-title":"Abatacept: a review in rheumatoid arthritis","volume":"77","author":"Blair","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.jaut.2017.12.012_bib160","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/ni.3655","article-title":"Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression","volume":"18","author":"Linke","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib161","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2017.12.012_bib162","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.celrep.2012.02.007","article-title":"PI3K-Akt-mTORC1-S6K1\/2 axis controls Th17 differentiation by regulating Gfi1 expression and nuclear translocation of RORgamma","volume":"1","author":"Kurebayashi","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.jaut.2017.12.012_bib163","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1172\/JCI37964","article-title":"Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3\/p63\/Jagged\/Notch cascade","volume":"120","author":"Ma","year":"2010","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.jaut.2017.12.012_bib164","doi-asserted-by":"crossref","first-page":"40817","DOI":"10.18632\/oncotarget.17256","article-title":"Rapamycin regulates macrophage activation by inhibiting NLRP3 inflammasome-p38 MAPK-NFkappaB pathways in autophagy- and p62-dependent manners","volume":"8","author":"Ko","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jaut.2017.12.012_bib165","doi-asserted-by":"crossref","first-page":"8338","DOI":"10.4049\/jimmunol.177.12.8338","article-title":"Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients","volume":"177","author":"Battaglia","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib166","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1586\/eci.11.76","article-title":"HLA associations and Lofgren's syndrome","volume":"8","author":"Grunewald","year":"2012","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.jaut.2017.12.012_bib167","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1399-0039.2007.00879.x","article-title":"Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis","volume":"70","author":"Spagnolo","year":"2007","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jaut.2017.12.012_bib168","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1007\/s11033-014-3318-z","article-title":"Associations between tumor necrosis factor alpha gene polymorphism and sarcoidosis: a meta-analysis","volume":"41","author":"Xie","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jaut.2017.12.012_bib169","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1034\/j.1399-0039.1999.540211.x","article-title":"Genetic polymorphisms at the tumour necrosis factor loci (TNFA and TNFB) in cardiac sarcoidosis","volume":"54","author":"Takashige","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jaut.2017.12.012_bib170","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1183\/09031936.00169413","article-title":"Association of the TNF-alpha G-308A polymorphism with TNF-inhibitor response in sarcoidosis","volume":"43","author":"Wijnen","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2017.12.012_bib171","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1399-0039.2005.00370.x","article-title":"Association of tumour necrosis factor-alpha, lymphotoxin-alpha and HLA-DRB1 gene polymorphisms with Lofgren's syndrome in Czech patients with sarcoidosis","volume":"65","author":"Mrazek","year":"2005","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jaut.2017.12.012_bib172","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.3201\/eid0811.020318","article-title":"Molecular analysis of sarcoidosis tissues for mycobacterium species DNA","volume":"8","author":"Drake","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jaut.2017.12.012_bib173","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1084\/jem.20040429","article-title":"Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis","volume":"201","author":"Song","year":"2005","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2017.12.012_bib174","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.resinv.2012.07.001","article-title":"Th1 and Th17 immune responses to viable Propionibacterium acnes in patients with sarcoidosis","volume":"50","author":"Furusawa","year":"2012","journal-title":"Respir. Investig."},{"key":"10.1016\/j.jaut.2017.12.012_bib175","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1128\/IAI.00732-06","article-title":"Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis","volume":"75","author":"Drake","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jaut.2017.12.012_bib176","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2796.2011.02414.x","article-title":"Multiparameter phenotyping of T-cell subsets in distinct subgroups of patients with pulmonary sarcoidosis","volume":"271","author":"Wiken","year":"2012","journal-title":"J.\u00a0Intern. Med."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841117308053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841117308053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:19:41Z","timestamp":1760257181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841117308053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":176,"alternative-id":["S0896841117308053"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2017.12.012","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Th17-lineage cells in pulmonary sarcoidosis and L\u00f6fgren's syndrome: Friend or foe?","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2017.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}